These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21846454)

  • 1. Is there a place for AMH testing in Canada?
    Green JA; Graves G
    J Obstet Gynaecol Can; 2011 Jun; 33(6):628-632. PubMed ID: 21846454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.
    Broer SL; Broekmans FJ; Laven JS; Fauser BC
    Hum Reprod Update; 2014; 20(5):688-701. PubMed ID: 24821925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measurement of serum AMH levels in gynecology: indications and limits].
    Streuli I; Cantero-Perez P; Miserez-Zaugg C
    Rev Med Suisse; 2013 Oct; 9(403):1954-6, 1958. PubMed ID: 24245018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti mullerian hormone (AMH)--is it a new reliable marker of the ovarian reserve? Its role in predicting the ovarian response in assisted reproductive technology (ART)].
    Alshiek JA; Lessing JB; Amit A; Azem F
    Harefuah; 2012 Jul; 151(7):416-20, 435. PubMed ID: 23002694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
    Tremellen K; Zander-Fox D
    Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the measurement of anti-Müllerian hormone essential?
    Usta T; Oral E
    Curr Opin Obstet Gynecol; 2012 Jun; 24(3):151-7. PubMed ID: 22487725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
    Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J
    Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti Müllerian Hormone: More than a biomarker of female reproductive function.
    Victoria M; Labrosse J; Krief F; Cédrin-Durnerin I; Comtet M; Grynberg M
    J Gynecol Obstet Hum Reprod; 2019 Jan; 48(1):19-24. PubMed ID: 30352309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Mullerian hormone (AMH): what do we still need to know?
    La Marca A; Broekmans FJ; Volpe A; Fauser BC; Macklon NS;
    Hum Reprod; 2009 Sep; 24(9):2264-75. PubMed ID: 19520713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
    Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
    Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of anti-Müllerian hormone in female fertility and infertility - an overview.
    Grynnerup AG; Lindhard A; Sørensen S
    Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1252-60. PubMed ID: 22646322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring anti-Müllerian hormone for the assessment of ovarian reserve: when and for whom is it indicated?
    Anderson RA; Nelson SM; Wallace WH
    Maturitas; 2012 Jan; 71(1):28-33. PubMed ID: 22119275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Müllerian hormone as a predictor of reproductive potential.
    Hawkins Bressler L; Steiner A
    Curr Opin Endocrinol Diabetes Obes; 2018 Dec; 25(6):385-390. PubMed ID: 30299431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Müllerian hormone dynamics during GNRH-antagonist short protocol for IVF/ICSI in women with varying ovarian reserve levels.
    Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
    Minerva Ginecol; 2017 Apr; 69(2):128-134. PubMed ID: 27310675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Ovarian Reserve Screening with Anti-Müllerian Hormone for Reproductive Age Women Deferring Pregnancy.
    Grossman LC; Safier LZ; Kline MD; Chan CW; Lobo RA; Sauer MV; Douglas NC
    J Womens Health (Larchmt); 2017 Apr; 26(4):345-351. PubMed ID: 27906603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders.
    Weintraub A; Margalioth EJ; Chetrit AB; Gal M; Goldberg D; Alerhand S; Eldar-Geva T
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():163-7. PubMed ID: 24630573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
    Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
    Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predictive value of anti-Mullerian hormone levels in serum and follicle fluid for IVF-ET outcomes in patients with polycystic ovarian syndrome].
    Chen X; Yin M; Ye D; He Y; Chen S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):546-9. PubMed ID: 23644117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.